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Abstract. To test the hypothesis that the T-cell receptor 
(Tcr) "y gene encodes a natural killer (NK) cell receptor 
molecule, three human NK clones and fresh peripheral 
blood lymphocytes with NK activity from two patients 
with a CDI6 ÷ lymphocytosis were analyzed for rear- 
rangements and expression of the human Tcr ~, /3, and 
7 genes. Two of the clones displayed distinct rearrange- 
ments of their Tcr/3 and 3' genes and expressed mature 
Tcr ~, /3, and 7 RNA. However, one of the clones and 
both patient samples displayed marked NK activity but 
failed to rearrange or express any of their Tcr genes. 
These findings demonstrate that human natural killer ac- 
tivity is not dependent on Tcr 7 gene rearrangement and 
expression. In addition, they confirm previous findings 
concerning the lack of Tcr ~ and/3 gene expression in 
some natural killer cells. Thus, they suggest the existence 
of additional NK-specific recognition molecules. 
Introduction 
Natural killer (NK) cells are a subset of lymphocytes that 
have been defined by their ability to recognize and kill 
a variety of tumor cell lines without prior sensitization 
(Herberman and Ortaldo 1981). Previous studies have 
clearly demonstrated that NK activity is mediated by a het- 
erogeneous population of cells which display different 
constellations of cell surface antigens and vary in their 
ability to recognize and kill specific tumor cell lines 
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(Zarling et al. 1981, Lanier et al. 1983, Pawelec et al. 
1982, Lopez-Botet et al. 1983, Hercend et al. 1983a, Or- 
taldo et al. 1981). The majority of NK cells present in 
normal human peripheral blood express the E-rosette 
receptor CD2 as well as the more NK-specific CD16 and 
Leu- 19 surface markers. However, most of these cells do 
not express the T-cell surface antigens CD3 or CD4 and 
display variable levels of expression of CD8. In contrast, 
a minority of peripheral blood cells which are capable of 
non-major histocompatibility complex (MHC) restricted 
killing display the CD3 ÷, CD4 ÷, and/or CD8 ÷ pheno- 
type characteristic of more mature peripheral blood T 
lymphocytes. The majority of NK cells appear to differ 
from cytotoxic T lymphocytes (CTL) in that their killing 
does not require recognition of target cell MHC antigens 
(Herberman and Ortaldo 1981). However, NK clones 
have been identified which are able to mediate both MHC- 
independent NK killing and MHC-dependent CTL activi- 
ty (Kornbluth et al. 1981, Kornbluth 1985, David et al. 
1987). 
The observed heterogeneity of NK cell surface pheno- 
type and cytotoxic activity has raised a number of fun- 
damental questions concerning both the lineage(s) of NK 
cells and the mechanisms used by these cells to recognize 
their tumor cell targets. Thus, it is unclear whether some 
or all NK cells are developmentally related to cells of the 
T lymphocyte lineage. In addition, the structures utilized 
by NK cells to recognize tumor cell antigens remain ob- 
scure. The in vitro growth of normal human NK clones 
(Hercend et al. 1983a, Kornbluth et al. 1981, Dennert 
1980, Kornbluth et al. 1982) and the molecular cloning 
of the genes encoding the human T-lymphocyte receptor 
for antigen (Hedrick et al. 1984a, b, Saito et al. 1984a, 
b, Yanagi et al. 1984, Sim et al. 1984, Chien et al. 1984b) 
have made possible studies which begin to address these 
questions. 
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Human helper and cytotoxic T cells recognize antigen 
via a heterodimeric, idiotypic T-cell receptor molecule 
which has been shown to be composed of acidic (o~) and 
basic (/3) glycoproteins each of relative mass 
40000-50000 (Allison et al. 1982, Haskins et al. 1983, 
Meuer et al. 1983). The genes encoding both chains of 
the receptor have been cloned and shown to be composed 
of germ line variable (V), diversity (D) (at least in the 
case of the Tcr~ genes), joining (J), and constant (C) 
gene segments which undergo specific rearrangements 
during T-cell ontogeny to produce mature Tcr c~ and/3 
genes (Hedrick et al. 1984a, b, Saito et al. 1984a, b, Yana- 
gi et al. 1984, Sim et al. 1984, Chien et al. 1984a, Clark 
et al. 1984, Gascoigne et al. 1984, Siu et al. 1984a, b). 
In addition, a third T-cell specific gene, 3", has been 
described which is also composed of rearranged variable, 
joining, and constant gene segments (Saito et al. 1984a, 
Hayday et al. 1985, Quertermous et al. 1986). The 
product of the human Tcr~ gene (in conjunction with a 
second chain termed 6) has recently been shown to be ex- 
pressed on the surface of CD3-- T cells from an im- 
munodeficiency patient as well as on the surface of several 
T-cell tumor lines and a small subset of normal adult and 
fetal peripheral blood T cells (Brenner et al. 1986, 1987, 
Weiss et al. 1986, Moingeon et al. 1987, Borst et al. 
1987). The function of the 3' gene product remains 
unknown, but several Tcrv expressing clones have been 
shown to be capable of mediating the non-MHC restricted 
killing of a variety of tumor cell targets (Moingeon et al. 
1987, Brenner et al. 1987, Borst et al. 1987). These find- 
ings have raised the possibility that the Tcr~ gene en- 
codes an NK antigen receptor molecule. 
In the studies described in this report, we have exam- 
ined the rearrangement and expression of Tcr ~, /3, and 
3' genes in three human NK clones which display different 
cell surface phenotypes, as well as in fresh peripheral 
blood lymphocytes (PBL) with NK activity from two pa- 
tients with a CD16 ÷ lymphocytosis. The results demon- 
strate that NK activity is not dependent on the rearrange- 
ment and expression of the Tcr~ gene complex. In 
addition, they confirm previous reports of the absence of 
Tcr c~ and/3 gene expression in some NK cells (Ritz et 
al. 1985, Yanagi et al. 1985, Reynolds et al. 1985, Lanier 
et al. 1986) and suggest a molecular mechanism which 
could explain the previously described dual NK and CTL 
function of certain NK clones. 
Materials and methods 
Isolation and characterization of  human NK clones. NK clones 3.3, IS, 
and 37 were derived from primary mixed lymphocyte culture (MLC)-ac- 
tivated PBL plated in soft agarose as previously described (Kornbluth 
et al. 1982). Cells were recloned twice in agarose and then expanded 
and maintained in medium consisting of RPMI 1640 supplemented with 
hydroxyethylpiperazine ethanesulfonic acid (HEPES; 25 mM), gluta- 
mine (2 mM), penicillin (100 units/ml), streptomycin (100 gg/ml), 15 % 
heat-inactivated pooled human serum (Bit-Bee, Boston, Massachusetts) 
and 15% interleukin-2 medium (Lymphocult-T, Biotest Diagnostics 
Corp., Fairfield, New Jersey). NK clone 3.3 was derived from the MLC 
responder-stimulator combination DMx, clone 1S from the combination 
BDx, and 37 from the MLC EJx. All of these clones have strong and 
exclusive NK activity (Kornbluth et al. 1982, and Table 1). NK function 
was assessed in 4-h 51Cr-release assays (Kornbluth et al. 1982) using 
the NK sensitive target cell lines K562, MOLT-4, and HSB-2. Control 
target cell lines included phytohemagglutinin-activated PBL derived 
from the MLC responder (designated auto) and stimulator (designated 
stim) donors used to generate the clones. Clones were phenotyped by 
indirect immunofluorescence flow cytometry using the monoclonal 
antibodies 9.6 (anti-CD2), 64.1 (anti-CD3), 66.1 (anti-CD4), and 
51.1 (anti-CD8) generously provided by Dr. John Hansen. The B73.1 
(anti-CD16) monoclonal antibody was kindly provided by Dr. Giorgio 
Trinchieri. 
Patient samples. Both of the patients in this study were seen on an outpa- 
tient basis at Rush-Presbyterian-St. Luke's Medical Center. Patient 1 
is a 56-year-old, otherwise healthy and asymptomatic female suspected 
of having chronic lymphocytic leukemia. Her absolute white blood cell 
count at the time of the study was 15 600/mm 3, with 66% lymphocytes 
and 34% polymorphonuclear lymphocytes (PMN). Patient 2 is a 
35-year-old asymptomatic male suspected of having chronic lymphocyt- 
ic leukemia. At the time of the study, his absolute white blood cell count 
was 25400/mm 3 with 57% lymphocytes, 24% PMN, 9% monocytes, 
and 10% eosinophils. Peripheral blood from both patients was sterilely 
collected into preservative-free heparin and subjected to Ficoll gradient 
separation, and the mononuclear population was then divided into ali- 
quots for direct irnmunofluorescence analysis and the preparation of 
DNA and RNA as described below. Cells were phenotyped by direct 
immunofluorescence flow cytometry on an EPICS C flow cytometer us- 
ing the following monoclonal reagents: Leu-5 (anti-CD2), Leu-4 (anti- 
CD3), Leu-3 (anti-CD4), Leu-2 (anti-CD8), Leu-11 (anti-CD16), IL-2R 
(anti-CD25), Leu-7, DR (anti-HLA-DR), and Leu-19 (Becton- 
Dickinson, Mountain View, California). The surface phenotypes of the 
patients' cells were determined at least three times over a 3-month 
period, and those of both patients remained stable. Cells from patient 
2 were fractionated into CD3 + and CD3-  populations by indirect pan- 
ning with Leu-4 and Leu- 12 on a goat anti-mouse antibody-coated plastic 
dish (Wysocki and Sato 1978) prior to the preparation of DNA and RNA. 
After panning, the nonadherent cells were 99% CD3- (data not 
shown). NK activity of the patient's cells was determined by a standard 
3-h 51Cr-release assay (Bray and Brahmi 1986) using the NK-sensitive 
target cell line K562. Cells were assayed both with and without 18 h 
of pretreatment with highly purified recombinant interleukin-2 (rlL-2) 
(Cetus, Emeryville, California) (100 units/ml). 
Southern blot analysis. High relative mass DNA was prepared according 
to the method of Bell and co-workers (1981) except that the spooling 
step was replaced by ethanol precipitation at - -  20 °C. Southern blotting 
was performed on a minigel system using from 1 to 5 Ixg high relative 
mass DNA per lane. Alkaline blotting to Zeta Probe nylon membranes 
(Biorad, Richmond, California) and hybridizations were performed fol- 
lowing the manufacturer's instructions except that 5% dextran sulfate 
(Oncor, Gaithersburg, Maryland) was included in some hybridizations. 
Probes were Tcr~, the 790 bp Xho I/Eco RI, or the 389 bp Bgl II con- 
stant region fragments from the Tcr~ eDNA 12A1 (Leiden et al. 1986a) 
from the T-cell tumor line HPB-MLT, and Tcr~, the 0.8 kb Hind 
III/Eco RI genomic DNA fragment containing the J~l.3 gene segment 
(Quertermous et al. 1986). 
Northern blot analysis. Whole NK cell RNA (1-10 Ixg) was prepared 
from 5 x l0 s to 5 × 106 NK cells and from the human T-cell tumor cell 
line HPB-ALL according to the urea/LiC12 method of Auffray and 
Rougeon (1980). Northern blotting was performed using a formaldehyde 
J .M.  Leiden et al.: T-cell receptor gene rearrangement in NK ceils 
Table 1. Phenotypic and functional characterization of three human NK clones 
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Clone Phenotype Antibody Cytolytic activity* (% lysis) 




CD2 +, CD16 +, CD3- ,  CD4- ,  C D8-  - -  48 50 47 ND* 
+CD3 I] 46 50 48 ND 
CD2 +, CD3 +, CD4 +, C D 8 -  - -  61 40 ND 5 
CD2 +, CD3 +, CD4 +, C D8-  - -  62 57 38 2 






* Clones were assayed at effector-to-target cell ratios of 3 : 1 
See Materials and methods for a description of auto and stim target cells 
* ND, not determined 
I[ CD3-specific antibody 64.1 was present as indicated throughout the cytotoxicity assays at a final ascites dilution of 1 : 500 
minigel system and Biotrans nylon membranes (ICN Biochemical, Plain- 
view, New York) according to standard techniques (Maniatis et al. 
1982). Prehybridization was for 2 h at 42 °C in 3 × standard sodium 
citrate (SSC), 50% formamide, 50 mM  HEPES (pH 7.0), 5 × Den- 
hardt's solution, 0.15 mg/ml denatured salmon sperm DNA, and 0.1% 
sodium dodecyl sulfate (SDS). 32p-labeled, nick-translated probe 
(2:,< 108 cpm/~tg) was added to the prehybridization mixture and 
hybridization was carried out for 16-20 h at 42 °C. Washing was per- 
formed for 2 × 15 min in 1 x SSC, 0.5% SDS, at room temperature fol- 
lowed by four 15-rain washes in 0.1 x SSC, at 55 °C. Autoradiography 
was performed for 1-10 days at - -70  °C using Dupont intensifying 
screens. Probes were Tcr~, the full-length Tcr,~ cDNA from the human 
T-cell clone L17 (Leiden et al. 1986b) in pUC18; Tcr~, the 12A1 Tcra 
cDNA from the human T-cell tumor line HPB-MLT (Leiden et al. 
1986a) in pUC18; and Tcrv, the Tcr v cDNA from the human T-cell 
tumor line HPB-MLT (Dialynas et al. 1986) in pUC13. 
Results 
Characterization of NKcells. The three human NK clones 
used in these studies were derived from MLC as described 
above. Clone 3.3 displays the surface phenotype (CD2 ÷, 
CD16 +, CD3-, CD4-, CD8-) characteristic of the 
majority of peripheral blood NK cells (Table 1). In con- 
trast, clones 1S and 37 display a surface phenotype more 
characteristic of mature peripheral blood T lymphocytes 
(CD2 +, CD3 +, CD4 ÷, CD8-) (Table 1). All three 
clones possess NK activity as defined by their ability to 
kill K562 human tumor cells (Table 1). This killing 
represents NK as opposed to CTL activity because all 
three cell lines fail to kill either their stimulator cells or 
cells expressing the same HLA antigens as their stimulator 
cells (Kornbluth et al. 1982 and Table 1). Moreover, 
neither clone 37 nor clone 3.3 killing of K562 targets is 
blocked by the addition of a monoclonal CD3-specific 
antibody (Table 1) which has been shown to block the 
CTL activity of a wide range of cytotoxic T-cell clones 
(Meuer et al. 1982). 
The peripheral blood from both patients contained a 
predominance of lymphocytes with a cell-surface pheno- 
type (CD2 +, CD16 ÷, CD3-, CD4-, CD8-) similar to 
that of NK clone 3.3 (Table 2) and the majority of 
peripheral blood NK cells. As previously described 
(Pistoia et al. 1986), the CD16 + cells from both patients 
are uniformly CD3-. However, the CD16 + cells from 
these two patients differ in their surface expression of the 
Leu-7 antigen in that the majority of the CD16 + lympho- 
cytes from patient 2 were strongly Leu-7 positive while 
only 19 % of the CD16 + cells from patient 1 coexpressed 
this antigen. Fresh peripheral blood cells from both of the 
patients displayed spontaneous NK activity as defined by 
MHC-independent cytotoxicity against the K562 target 
cell line (Table 3). rlL-2 treatment increased the NK ac- 
tivity of cells from both of the patients. 
Rearrangement of Tcr genes in the NK cells. Southern blot 
analyses ofEco RI-, Hind HI-, and Bam HI-digested NK- 
cell and control B-cell DNAs revealed that the NK clones 
Table 2. Phenotypic characterization of freshly isolated peripheral blood 
mononuclear ceils from two patients with a CD16 ÷ lymphocytosis* 
Antigen (Normal Patient 1 Patient 2 
range) 
CD2 (58-86) 98 96 
CD3 (53-81) 14 32 
CD4 (23-58) 5 16 
CD8 (13-23) 8 18 
CD16 (5-20) 83 53 
CD25 (2-4) < 2 8 
Leu-7 (5-20) 19 69 
HLA-DR ( < 2) 79 27 
Leu-19 (5-20) 80 8 
* Direct immunofluorescence was performed on Ficoll gradient-purified 
mononuclear cells on an EPICS C flow cytometer as described in 
Materials and methods. Results represent the percentage of PBL posi- 
tive for a given marker. Note that both patients have very few circulat- 
ing peripheral blood B ceils as evidenced by the high percentage of 
CD2 + cells 
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Table 3. NK cytolytic activity of peripheral blood mononuclear cells 
from two patients with a CD16 + lymphocytosis 
Patient rIL-2* Cytolytic 
activity 
1 - -  185 
+ 295 
2 - -  42 
+ 116 
* Cells were incubated in RPMI 1640, 10% FCS, and recombinant IL-2 
(100 units/ml) for 18 h at 37 °C prior to the cytotoxicity assay 
Cytotoxicity is expressed as lytic units/107 cells. One lyric unit equals 
the number of  effector cells required to produce 20% specific lysis 
of 51Cr-labeled K562 target cells (see Materials and methods). 
Cytotoxicity assays were performed at effector-to-target ratios of 40, 
20, 10, and 5 : 1, and results represent the mean lyric units of all four 
ratios. The mean values for healthy laboratory control PBLs are 30-90 
and patient isolates can be divided into two groups based 
on their Tcr gene rearrangements. The CD3 + 1S and 
37 clones both displayed distinct Tcr 13 (Fig. 1A) and 3' 
(Fig. 1B) gene rearrangements, while the CD3- 
3.3 clone (Fig. 1) and the two patient samples (Fig. 2; 
patient 1, A and B; patient 2, C and D) displayed a germ- 
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line configuration of Tcr t3 and 3' genes which was 
identical with that of the control B-cell DNAs. 
Although the fresh patient isolates did not appear to 
display a clonal pattern of Tcr gene rearrangement by 
Southern blot analysis, it could be argued that, as is true 
of normal PBL, the patient samples are composed of a 
large number of heterogeneous clones which have under- 
gone multiple, distinct Tcr~ gene rearrangements (which 
would not be detected as distinct rearranged bands in this 
Southern blotting system). This is unlikely for three rea- 
sons. (i) The intensities of the Hind III 3.5 kb C~l-con- 
taining bands (Fig. 2, lanes A3 and C3) are almost identi- 
cal with those of the 6.7 kb Hind III bands from these 
samples, as well as with those of the analogous control 
bands (Fig. 2, lanes A4 and C4). This pattern is quite dis- 
tinct from that seen in polyclonal Tcr~ gene rearranging 
T-cell populations (such as normal PBL) which reveal sig- 
nificant decreases in the intensity of the 3.5 kb band, often 
accompanied by smearing in the region of the 10.0 kb 
germ-line Eco RI-C~I containing band (data not shown). 
(ii) As shown in Figure 3, at least patient sample 2 does 
not show evidence of Tcr~ RNA expression which al- 
ways appears to accompany Tcr~ gene rearrangement. 
(iii) In all cases previously studied, Tcr~ gene rearrange- 
ment has preceded Tcr~ gene rearrangement. These 3' 
Fig. 1A and B. Southern blot analysis of Tcr gene rearrangements in NK clones. Clone 9 (C19) is an Epstein-Barr virus (EBV) transformed B 
lymphoblastoid cell line with germ line Tcr ~ and "y genes (Leiden et al. 1986). 3.3, 1S, and 37 are NK clones (see Table 1). BK is DNA isolated 
from the whole blood of a healthy volunteer. Three to five micrograms of DNA was digested with the appropriate restriction enzyme and loaded 
into each well. Size markers in kilobases are shown to the left of each set of blots. A Analysis of  Tcr~ gene rearrangements in human NK clones. 
The 10.5 kb Eco RI band from the 37 clone (lane A3) is reproducibly larger than the germ-line 10.0 kb Eco RI band and therefore represents 
a Tcr~ gene rearrangement in this clone. The 9.0 kb C~-containing Eco RI bands in the 37 and 3.3 cell lines (lanes A3 and 4) are due to a partially 
resistant Eco RI site near the C~2 gene segment (Furley et al. 1986) and therefore do not represent Tcr~ gene rearrangements. B Analysis of Tcr v 
gene rearrangements in human NK clones. The 5.0 kb Jr-containing Hind III band in the 3.3 lane (lane B10) does not represent a Tcr~ gene rear- 
rangement but is due to the absence of a previously reported polymorphic Hind III site (Giuseppe et al. 1987) from one allele of this clone. This 
site is also absent from one allele of the DNA isolated from a healthy volunteer (BK; lane B9) 
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Fig. 2A-D.  Southern blot analysis of Tcr gene rearrangements in PBL from two patients with a CD16 + lymphocytosis. One to five micrograms 
of DNA from either the clone 9 (C19) B lymphoblastoid control cell line (see legend to Fig. 1), a healthy volunteer (BK), or from the PBL from 
patient 1 (NK; A and B) or patient 2 (NK; C and D) was digested with the appropriate restriction enzyme and loaded in each lane. Blots were 
probed with either Tcr/3 (A and C) or 7 (B and D) specific probes (see Materials and methods). Size markers in kilobases are shown to the left 
of each set of blots. The 9.0 kb C~-containing Eco RI band in the C19 sample (lane C2) reflects a partially resistant Eco RI site near the C~2 gene 
(see legend to Fig. 1). The 5.0 kb Jr-containing Hind III band in patient sample 2 (lane D3) represents the absence of a polymorphic Hind III 
site in one allele from this patient (see legend to Fig. 1) and is also absent from one unrearranged Tcr~ allele from a normal volunteer (BK; lane D5) 
gene rearrangements are visible even on Southern blots 
of polyclonal T-cell populations (Quertermous et al. 
1986). Thus, the finding that the 3.3 clone and the patient 
samples display a germ-line pattern of Tcr~ genes is con- 
sistent with the finding that their Tcr¢ genes also remain 
in a germ-line configuration. 
Expression of Tcr genes in the NK cells. To determine 
whether the NK cells described in this report express Tcr 
genes, RNA from the three clones and one of the patient 
samples was subjected to Northern blot analyses using Tcr 
o~,/3, and 3' specific probes (Figs. 3 and 4). Prior studies 
have shown that there are two forms of poly(A) + Tcr~ 
RNA: a mature 1.3 kb transcript, representing a function- 
al V-D-JC rearrangement and a 1.0 kb transcript, 
representing a D-JC rearrangement which lacks V region 
sequences (Clark et al. 1984). Full-length Tcr c~ and 3' 
transcripts are both 1.6 kb in size (Sim et al. 1984, Dialy- 
Fig. 3A-E.  Northern blot analysis of  Tcr gene expression in human NK clones. One to five micrograms of whole RNA from NK clones 3.3, 37, 
and 1S, the human T-cell tumor cell line HPB-ALL, or the B-lymphoblastoid cell line JY was loaded into each lane and subjected to Northern 
blot analysis as described in Materials and methods. The sizes of  the previously characterized Tcr c~ (A and D),/3 (B and E), and 3' (C) mRNAs 
are shown in kilobases to the left of each blot. The relatively light intensities of  the Tcr~ bands in D are due to the fact that this blot had been 
previously hybridized to a Tcra probe, stripped by treatment with 80% formamide, 0.1 x SSC, at 68 °C, and reprobed with the Tcr,  probe 
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Discussion 
Fig. 4A-C.  Northern blot analysis of  Tcr gene expression in the PBL 
from one patient with a CD16 + lymphocytosis. One to five micrograms 
of whole RNA from the human T-cell tumor line HPB-ALL or from 
the unfracfionated PBL (CD3 +/-) or the C D 3 -  cells from this patient 
was loaded in each lane and subjected to Northern blot analysis as 
described in Materials and methods. The sizes of the previously charac- 
terized Tcr/3 (A) and 3, (B and C) mRNAs are shown in kilobases to 
the l e f t  of each set of blots. Two different RNA samples are shown in 
B and C. In C, 1 ~tg and 10 Ixg of HPB-ALL RNA are compared with 
1 ~tg of RNA from the C D 3 -  cells from patient 2. Hybridization of a 
similar blot to a Tcr~ probe failed to detect any Tcr~ RNA in the CD3-  
ceils from this patient (data not shown). Autoradiograms have been inten- 
tionally overexposed to rule out low level Tcr gene expression by these 
cells 
nas et al. 1986). Examples of these full-length Tcr tran- 
scripts are shown from the well-characterized human T- 
cell tumor cell line HPB-ALL (Figs. 3 and 4). 
As seen in Figures 3 and 4 and summarized in Table 
4, the NK clones can be divided into two subsets based 
on their patterns of Tcr gene expression. The CD3 ÷ 
clones 37 and 1S express full-length Tcr o~ and/3 (Fig. 
3D and E) RNAs, while the CD3- 3.3 clone and the 
CD3-, CD16 ÷ cells from patient 2 do not express detect- 
able levels of full-length Tcr RNA. By loading five times 
more RNA and overexposing the autoradiograms, clone 
3.3 can be shown to express very low levels of short Tcr 
/3 (1.0 kb) and 3' (1.3 kb) RNAs (data not shown). These 
RNA species presumably reflect low level transcription 
of the unrearranged Tcr genes present in this clone. 
The present studies of Tcr gene rearrangement and ex- 
pression in normal human NK clones and fresh PBL with 
NK activity from two patients with a CD16 + lymphocy- 
tosis provide information concerning both the lineage and 
function of human peripheral blood NK cells. First, the 
results demonstrate that human NK function is not depen- 
dent upon Tcrv gene rearrangement and expression. In 
addition, they confirm previous studies which have shown 
that NK activity is not dependent on Tcr oL//3 gene rear- 
rangement and expression (Ritz et al. 1985, Yanagi et al. 
1985, Reynolds et al. 1985, Lanier et al. 1986). Thus, 
they suggest the existence of alternate NK receptor struc- 
tures. 
Furthermore, the present data, when taken together 
with previous reports, allow the delineation of at least four 
subsets of cells which are capable of mediating the non- 
MHC restricted killing of tumor cell targets. The first sub- 
set, which is represented in this study by the CD16 +, 
CD3-, CD4-, CD8- 3.3 clone and both flesh patient 
isolates, is probably representative of the majority of 
peripheral blood NK cells, at least by cell-surface pheno- 
type. This subset of NK cells does not rearrange or express 
any of the known Tcr genes. The finding that the CD3- 
3.3 clone and the CD3- cells from patient 2 do not ex- 
press mature Tcr a, /3, or 3, transcripts and, therefore, 
presumably cannot express a mature Tcr molecule on their 
surfaces is in agreement with the previous observation that 
CD3 and Tcr cell-surface expression are tightly coupled 
(Weiss et al. 1984). 
The IS and 37 clones represent a second class of T 
cells which are capable of mediating the non-MHC re- 
stricted killing of NK targets. These clones, which display 
a cell-surface phenotype similar to that of mature 
peripheral blood T cells, rearrange their Tcr/3 and 3' genes 
and express full-length Tcr ~ and/3 transcripts. Therefore, 
they probably express functional Tcr molecules on their 
surface. This is in accord with the finding that both clones 
are CD3 + . While we cannot rule out the possibility that 
Table 4. Summary of Tcr gene rearrangement and expression in human NK clones and PBL from two patients with a CD16 + lymphocytosis 
Clone Phenotype Tcr gene rearrangement Tcr gene expression 
13 3' ~ /3 ,y 
NK 3.3 CD2 +, CD16 +, CD3- ,  CD4- ,  C D 8 -  2 g l *  2 g l  - -  - -  - -  
NK IS CD2 +, CD3 +, CD4 +, C D 8 -  2 r  t 2 r  + 1.3/1.0" ND 
NK 37 CD2 +, CD3 +, CD4 +, C D 8 -  2 r  2 r  + 1.3/1.0 ND 
Pt. 1 CD2 +, CD16 +, CD3- ,  CD4- ,  C D 8 -  2 g l  2 g l  ND II ND ND 
Pt. 2 CD2 +, CD16 +, CD3- ,  CD4- ,  C D 8 -  2 g l  2 g l  - -  - -  - -  
* gl, germ-line. The number of  alleles in each configuration is shown 
t r, rearranged 
* The size of the Tcr~ RNA is shown in kilobases 
II ND, not determined 
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these cells express a Tcr ~//6 receptor in association with 
CD3, it is far more likely that they express a CD3 associat- 
ed or//3 Tcr. All previously described Tcr 3"/6 expressing 
cells display the C D 4 - / C D 8 -  surface phenotype and fail 
to coexpress full-length Tcr ~ and/3 transcripts. In con- 
trast, both the 1S and 37 NK clones express the CD4 anti- 
gen, and both express full-length Tcr o~ and/3 transcripts. 
Because clone 37 killing of K562 targets is not inhibited 
by the addition of CD3-specific antibody, we would argue 
that the NK activity of this clone is not mediated by the 
Tcr/CD3 complex and would postulate that Tcr gene ex- 
pression in this clone (and perhaps others with a similar 
cell-surface phenotype) may represent a coincident find- 
ing which is not related to its ability to recognize and kill 
NK targets. In fact, it is interesting to note that a subset 
of NK clones has been identified which express both NK 
and CTL activity (Kornbluth et al. 1981, Kornbluth 
1985). These results could be explained if such cells utilize 
Tcr molecules for CTL function and a second, putative 
NK receptor for natural killing activity. 
Two additional subsets of cells have been described 
which both appear to be capable of mediating the non- 
MHC restricted killing of NK targets via cell-surface 
Tcr/CD3 complexes. First, several CD3+/Tcr c~//3 + NK 
clones have been described (Hercend et al. 1983b, David 
et al. 1987). Unlike clone 37, the killing of K562 targets 
by these CD3 + clones is blocked by both monoclonal 
anti-CD3 reagents and by a monoclonal idiotype-specific 
antibody directed against the Tcr od/3 molecule present 
on the clones. Moreover, several of these clones have also 
been shown to mediate allo-CTL activity via their 
CD3/Tcr receptors (David et al. 1987). In addition, sever- 
al Tcr 3,/6 + clones have been described which mediate 
non-MHC restricted cytotoxic activity which is also 
blocked by idiotype-specific and CD3-specific mono- 
clonal antibodies (Moingeon et al. 1987, Brenner et al. 
1987, Borst et al. 1987). Whether the non-MHC restricted 
killing mediated by these two subsets of Tcr expressing 
cells represents an artifact of prolonged in vitro culture 
in IL-2 or alternatively is representative of their bona fide 
in vivo function requires further study. 
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Note added in proof: 
During the preparation of this manuscript, Lanier and co-workers (J. 
Immunol. 137: 3375-3377, 1986) reported that freshly isolated CD16 + 
human peripheral blood NK cells display a germ-line pattern of Tcr~ 
genes. 
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